U.S. and China regulators have now cleared Sineugene Therapeutics' ALS gene therapy SNUG01 for clinical trials.

United States of America's Miss Ohio 2025 Tamera Carter will join hundreds of walkers and community partners on Sept. 14 to ...

As the professional title suggests, speech-language pathologists assess and treat more than just speech disabilities. They ...

Sometimes, an illness creates a sudden need to find a Plan B. Thanks to Jeff Bezos, you can now become a landlord for as ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes the gradual loss of motor neurons in the brain and spinal cord, leading to muscle weakness, paralysis, and ...

Many people will never know the last time they will do certain things in life. Even though he navigates sometimes trying days ...

Scientists have created a lifelike model of Amyotrophic Lateral Sclerosis (ALS), a type of motor neuron disease, using cells ...

This year's ALS Nexus conference allowed the community to connect with each other, celebrate recent advances, and share hope ...

A compound normally associated with red blood cells may also play a game-changing antioxidant role in the brain, a study has ...

Yet another biotech is facing a delay from the FDA as the agency reels from intense staffing cuts. | Yet another biotech is ...

Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease that slowly robs people of their ability to move, speak, swallow, and even breathe.